Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
155.88
+0.49 (0.32%)
Jul 17, 2026, 10:46 AM EDT - Market open
Glaukos Employees
Glaukos had 1,094 employees as of December 31, 2025. The number of employees increased by 99 or 9.95% compared to the previous year.
Employees
1,094
Change (1Y)
99
Growth (1Y)
9.95%
Revenue / Employee
$503,975
Profits / Employee
-$173,060
Market Cap
9.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,094 | 99 | 9.95% |
| Dec 31, 2024 | 995 | 88 | 9.70% |
| Dec 31, 2023 | 907 | 124 | 15.84% |
| Dec 31, 2022 | 783 | 56 | 7.70% |
| Dec 31, 2021 | 727 | 74 | 11.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| STERIS | 17,937 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
| Bruker | 11,085 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
| Insulet | 5,400 |
GKOS News
- 2 hours ago - Glaukos price target raised to $175 from $170 at Stifel - TheFly
- 1 day ago - Glaukos price target raised to $180 from $160 at Truist - TheFly
- 4 days ago - Glaukos price target raised to $164 from $162 at BTIG - TheFly
- 9 days ago - Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29 - Business Wire
- 9 days ago - Glaukos price target raised to $175 from $162 at Citi - TheFly
- 11 days ago - Glaukos initiated with a Buy at H.C. Wainwright - TheFly
- 22 days ago - Glaukos completes patient enrollment in Phase 2 study of GLK-321 - TheFly
- 22 days ago - Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis - Business Wire